Oncopharmpod
Umbralisib
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:13:46
- Mas informaciones
Informações:
Sinopsis
Discussing the latest TKI approval, umbralisib, and its familiar toxicity profile. Also, a few final words on a new CAR-T product and a cemiplimab expanded approval.
